Global Novel Drug Delivery Systems Market Growth (Status and Outlook) 2024-2030
The Novel Drug Delivery Systems market, valued at US$ 23.77 billion in 2023, is forecasted to reach US$ 26.87 billion by 2030 with a 1.8% CAGR, driven by growing downstream demand.
- Bonafide Trust
- 04-01-2024
- Pages : 151
- Figures : 79
- Tables : 163
- Region : Global
- Category : Lifescience
- Healthcare
According to Publisher’s latest study, the global Novel Drug Delivery Systems market size was valued at US$ 23770 million in 2023. With the growing demand in the downstream market, the Novel Drug Delivery Systems is forecast to a readjusted size of US$ 26870 million by 2030 with a CAGR of 1.8% during the review period. Market Overview
What's Inside a Bonafide Research`s industry report?
Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally
Download SampleThe research report highlights the growth potential of the global Novel Drug Delivery Systems market. Novel Drug Delivery Systems are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Novel Drug Delivery Systems. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Novel Drug Delivery Systems market. Novel Drug Delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for the delivery of drugs other than conventional drug delivery systems. NDDS is a combination of advanced techniques and new dosage forms which are far better than conventional dosage forms. The advantages of a Novel Drug Delivery System are Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Benefit to patients, better therapy, and improved comfort and standard of living.
Key Features: The report on the Novel Drug Delivery Systems market reflects various aspects and provides valuable insights into the industry. Market Size and Growth: The research report provides an overview of the current size and growth of the Novel Drug Delivery Systems market. It may include historical data, market segmentation by Type (e.g., Liposomes, PEGylated Proteins & Polypeptides), and regional breakdowns.
Market Drivers: Growing Requirement for Medication Release Under Control Novel drug delivery systems (NDDS), particularly controlled drug delivery systems, are employed for a variety of medical therapies because of their increased efficacy and decreased side effects. Pharmaceutical businesses can benefit from both improved drug delivery mechanisms and therapeutic compounds that are safer and more effective in treating diseases. These agents also present appealing marketing opportunities. Because these NDDS precisely deliver medication to the target location at the appropriate time and tempo, based on the body's physiological and etiological needs, they are considered the greatest drug delivery systems. These drug delivery systems are therefore widely used to treat a wide range of chronic illnesses, such as diabetes, cardiovascular disease, neurological disorders, and kidney issues. The need for medications with controlled release mechanisms is probably going to increase as the frequency of different chronic diseases rises. Advances in Technology and Pharmacology. Many developments in biology have made it possible to design novel drugs and biologics based on the molecular origins of human diseases. Newer drug delivery techniques include lipid, protein, and polymer technologies that have better lipid dispersion in the body. This decreases the rate of medication clearance and stops drug deterioration caused by the external environment. The use of nanotechnology in the pharmaceutical business (micro and nanoelectromechanical systems) has led to the creation of many novel drug delivery systems, such as nano beacon and mini beacons, Trojan horse nanoparticles, MEMS, and NEMS. The "Cochleate delivery vehicles" are a novel lipid-based system that provides a state-of-the-art technology platform for the systemic and oral delivery of pharmaceuticals. Challenges- Tight Regulations and Recalls of Products. Concerns regarding the safety and effectiveness of drugs in NDDS have prompted governments all over the world to establish regulatory bodies to oversee the development and marketing of NDDS-related pharmaceuticals and medical equipment. There is a chance that any medication employed in the biological system won't work out well. Most drugs have a favourable risk-to-benefit ratio, which indicates that using the drug has more advantages than disadvantages. On the other hand, there have been sad instances where people have suffered grave injuries due to drugs. Dangerous pharmaceuticals and phoney or counterfeit medications can induce significant adverse reactions that go unnoticed. These issues necessitate effective drug regulation to ensure the safety and effectiveness of pharmaceuticals for the public. Technological Developments: The research report can delve into the latest technological developments in the Novel Drug Delivery Systems industry. This includes advancements in Novel Drug Delivery Systems technology, Novel Drug Delivery Systems new entrants, Novel Drug Delivery Systems new investment, and other innovations that are shaping the future of Novel Drug Delivery Systems. Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Novel Drug Delivery Systems market. It includes factors influencing customers' purchasing decisions, and preferences for Novel Drug Delivery Systems products. Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provides market forecasts and outlook for the Novel Drug Delivery Systems industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments. Opportunities: Micro-Based Emulsions as Innovative Drug Administration Methods Microemulsions are isotropic, transparent blends of water, oil, and surfactant that are frequently combined with a cosurfactant. Pharmaceutical experts are currently interested in these systems due to their significant potential to function as drug-delivery vehicles by integrating a variety of pharmacological compounds. This paper reviews the use of microemulsions and closely related microemulsion-based systems as drug delivery vehicles, with a focus on current trends and potential future advances. Market Segmentation: Novel Drug Delivery Systems market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value. In terms of product, PEGylated Proteins & Polypeptides is the largest segment, with a share of about 40%. In terms of application, the largest application is Hospitals & clinics, followed by Cancer Treatment Centers, etc. 1. Segmentation by type • Liposomes • PEGylated Proteins & Polypeptides • Polymer Nanoparticle • Protein–drug Conjugates • Others 2. Segmentation by application • Hospitals & Clinic • Cancer Treatment Centres • Others Regional Insights: The largest revenue contributor in terms of market share for innovative drug delivery systems worldwide is North America. The United States is leading the market for factors such as an increase in funding for the discovery of novel pharmaceuticals, a rise in research activities related to new medicines, and a rise in public awareness of novel drug delivery techniques. The US market for novel drug delivery systems is primarily being driven by the high prevalence of chronic diseases, the increasing tendency for drug self-administration, improvements in injectable drug delivery systems, and high acceptance rates of new healthcare technologies. The Canadian market is well-established, with severe competition from both domestic and foreign players. The enhanced healthcare system in the country provides excellent services. The ageing population and the rise in chronic illnesses are driving growth in the French market and creating a strong need for innovative drug delivery methods. Significant cardiovascular disease risk factors are present in one in three French adults, according to the Foundation de France. Medication delivery systems are in high demand because of illnesses including diabetes, hypertension, cardiovascular disorders, and others. According to a 2018 study published in Circulation Research, cardiovascular illnesses are shown to be the country's biggest cause of death, even though neurological disorders, cancer, and infectious diseases offer more serious risks to the populace. Drug delivery systems address these conditions to lessen the possibility of side effects. Opportunities for local market expansion will also arise from the launch of new products. Asia-Pacific is expected to increase at a substantial rate over the projection period. In the market for innovative medicine delivery systems, China leads. The primary factors driving the market under examination in China are the growing prevalence of chronic illnesses like cancer and cardiovascular disease as well as the growing amount of research being done on cutting-edge technologies in the pharmaceutical sector. According to the Pharmaceutics China 2020 market research that was published in the American Journal of Advanced Drug Delivery, China implemented new drug administration regulations to expedite product registration and protect intellectual property rights (IPR). North America is the largest market, with a share of about 50%, followed by Asia-Pacific and Europe, both have a share of over 40 per cent. 3. Americas • United States • Canada • Mexico • Brazil 4. APAC • China • Japan • Korea • Southeast Asia • India • Australia 5. Europe • Germany • France • UK • Italy • Russia 6. Middle East & Africa • Egypt • South Africa • Israel • Turkey • GCC Countries Competitive Landscape: Global Novel Drug Delivery System's key players include Amgen, Teva, Roche, UCB (Union Chimique Belge), etc. Global top four manufacturers hold a share of over 40%. The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, and market penetration. • Amgen • Teva • Roche • UCB (Union Chimique Belge) • Celgene • Merck • Gilead Sciences • Sanofi • Pfizer • Takeda • Bausch&Lomb • Samyang Biopharmaceuticals • Johnson & Johnson • TOLMAR • Astellas • AMAG Pharmaceuticals • AbbVie • Dr Reddy • AstraZeneca • Aspen • Acrotech Biopharma • TWi Pharmaceuticals
Table of Contents
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Novel Drug Delivery Systems Market Size 2019-2030
- 2.1.2 Novel Drug Delivery Systems Market Size CAGR by Region 2019 VS 2023 VS 2030
- 2.2 Novel Drug Delivery Systems Segment by Type
- 2.2.1 Liposomes
- 2.2.2 PEGylated Proteins & Polypeptides
- 2.2.3 Polymer Nanoparticle
- 2.2.4 Protein–drug Conjugates
- 2.2.5 Others
- 2.3 Novel Drug Delivery Systems Market Size by Type
- 2.3.1 Novel Drug Delivery Systems Market Size CAGR by Type (2019 VS 2023 VS 2030)
- 2.3.2 Global Novel Drug Delivery Systems Market Size Market Share by Type (2019-2024)
- 2.4 Novel Drug Delivery Systems Segment by Application
- 2.4.1 Hospitals & Clinic
- 2.4.2 Cancer Treatment Centers
- 2.4.3 Others
- 2.5 Novel Drug Delivery Systems Market Size by Application
- 2.5.1 Novel Drug Delivery Systems Market Size CAGR by Application (2019 VS 2023 VS 2030)
- 2.5.2 Global Novel Drug Delivery Systems Market Size Market Share by Application (2019-2024)
- 3 Novel Drug Delivery Systems Market Size by Player
- 3.1 Novel Drug Delivery Systems Market Size Market Share by Players
- 3.1.1 Global Novel Drug Delivery Systems Revenue by Players (2019-2024)
- 3.1.2 Global Novel Drug Delivery Systems Revenue Market Share by Players (2019-2024)
- 3.2 Global Novel Drug Delivery Systems Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
- 4 Novel Drug Delivery Systems by Regions
- 4.1 Novel Drug Delivery Systems Market Size by Regions (2019-2024)
- 4.2 Americas Novel Drug Delivery Systems Market Size Growth (2019-2024)
- 4.3 APAC Novel Drug Delivery Systems Market Size Growth (2019-2024)
- 4.4 Europe Novel Drug Delivery Systems Market Size Growth (2019-2024)
- 4.5 Middle East & Africa Novel Drug Delivery Systems Market Size Growth (2019-2024)
- 5 Americas
- 5.1 Americas Novel Drug Delivery Systems Market Size by Country (2019-2024)
- 5.2 Americas Novel Drug Delivery Systems Market Size by Type (2019-2024)
- 5.3 Americas Novel Drug Delivery Systems Market Size by Application (2019-2024)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Novel Drug Delivery Systems Market Size by Region (2019-2024)
- 6.2 APAC Novel Drug Delivery Systems Market Size by Type (2019-2024)
- 6.3 APAC Novel Drug Delivery Systems Market Size by Application (2019-2024)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 7 Europe
- 7.1 Europe Novel Drug Delivery Systems by Country (2019-2024)
- 7.2 Europe Novel Drug Delivery Systems Market Size by Type (2019-2024)
- 7.3 Europe Novel Drug Delivery Systems Market Size by Application (2019-2024)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Novel Drug Delivery Systems by Region (2019-2024)
- 8.2 Middle East & Africa Novel Drug Delivery Systems Market Size by Type (2019-2024)
- 8.3 Middle East & Africa Novel Drug Delivery Systems Market Size by Application (2019-2024)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Global Novel Drug Delivery Systems Market Forecast
- 10.1 Global Novel Drug Delivery Systems Forecast by Regions (2025-2030)
- 10.1.1 Global Novel Drug Delivery Systems Forecast by Regions (2025-2030)
- 10.1.2 Americas Novel Drug Delivery Systems Forecast
- 10.1.3 APAC Novel Drug Delivery Systems Forecast
- 10.1.4 Europe Novel Drug Delivery Systems Forecast
- 10.1.5 Middle East & Africa Novel Drug Delivery Systems Forecast
- 10.2 Americas Novel Drug Delivery Systems Forecast by Country (2025-2030)
- 10.2.1 United States Novel Drug Delivery Systems Market Forecast
- 10.2.2 Canada Novel Drug Delivery Systems Market Forecast
- 10.2.3 Mexico Novel Drug Delivery Systems Market Forecast
- 10.2.4 Brazil Novel Drug Delivery Systems Market Forecast
- 10.3 APAC Novel Drug Delivery Systems Forecast by Region (2025-2030)
- 10.3.1 China Novel Drug Delivery Systems Market Forecast
- 10.3.2 Japan Novel Drug Delivery Systems Market Forecast
- 10.3.3 Korea Novel Drug Delivery Systems Market Forecast
- 10.3.4 Southeast Asia Novel Drug Delivery Systems Market Forecast
- 10.3.5 India Novel Drug Delivery Systems Market Forecast
- 10.3.6 Australia Novel Drug Delivery Systems Market Forecast
- 10.4 Europe Novel Drug Delivery Systems Forecast by Country (2025-2030)
- 10.4.1 Germany Novel Drug Delivery Systems Market Forecast
- 10.4.2 France Novel Drug Delivery Systems Market Forecast
- 10.4.3 UK Novel Drug Delivery Systems Market Forecast
- 10.4.4 Italy Novel Drug Delivery Systems Market Forecast
- 10.4.5 Russia Novel Drug Delivery Systems Market Forecast
- 10.5 Middle East & Africa Novel Drug Delivery Systems Forecast by Region (2025-2030)
- 10.5.1 Egypt Novel Drug Delivery Systems Market Forecast
- 10.5.2 South Africa Novel Drug Delivery Systems Market Forecast
- 10.5.3 Israel Novel Drug Delivery Systems Market Forecast
- 10.5.4 Turkey Novel Drug Delivery Systems Market Forecast
- 10.5.5 GCC Countries Novel Drug Delivery Systems Market Forecast
- 10.6 Global Novel Drug Delivery Systems Forecast by Type (2025-2030)
- 10.7 Global Novel Drug Delivery Systems Forecast by Application (2025-2030)
- 11 Key Players Analysis
- 11.1 Amgen
- 11.1.1 Amgen Company Information
- 11.1.2 Amgen Novel Drug Delivery Systems Product Offered
- 11.1.3 Amgen Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.1.4 Amgen Main Business Overview
- 11.1.5 Amgen Latest Developments
- 11.2 Teva
- 11.2.1 Teva Company Information
- 11.2.2 Teva Novel Drug Delivery Systems Product Offered
- 11.2.3 Teva Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.2.4 Teva Main Business Overview
- 11.2.5 Teva Latest Developments
- 11.3 Roche
- 11.3.1 Roche Company Information
- 11.3.2 Roche Novel Drug Delivery Systems Product Offered
- 11.3.3 Roche Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.3.4 Roche Main Business Overview
- 11.3.5 Roche Latest Developments
- 11.4 UCB (Union Chimique Belge)
- 11.4.1 UCB (Union Chimique Belge) Company Information
- 11.4.2 UCB (Union Chimique Belge) Novel Drug Delivery Systems Product Offered
- 11.4.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.4.4 UCB (Union Chimique Belge) Main Business Overview
- 11.4.5 UCB (Union Chimique Belge) Latest Developments
- 11.5 Celgene
- 11.5.1 Celgene Company Information
- 11.5.2 Celgene Novel Drug Delivery Systems Product Offered
- 11.5.3 Celgene Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.5.4 Celgene Main Business Overview
- 11.5.5 Celgene Latest Developments
- 11.6 Merck
- 11.6.1 Merck Company Information
- 11.6.2 Merck Novel Drug Delivery Systems Product Offered
- 11.6.3 Merck Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.6.4 Merck Main Business Overview
- 11.6.5 Merck Latest Developments
- 11.7 Gilead Sciences
- 11.7.1 Gilead Sciences Company Information
- 11.7.2 Gilead Sciences Novel Drug Delivery Systems Product Offered
- 11.7.3 Gilead Sciences Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.7.4 Gilead Sciences Main Business Overview
- 11.7.5 Gilead Sciences Latest Developments
- 11.8 Sanofi
- 11.8.1 Sanofi Company Information
- 11.8.2 Sanofi Novel Drug Delivery Systems Product Offered
- 11.8.3 Sanofi Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.8.4 Sanofi Main Business Overview
- 11.8.5 Sanofi Latest Developments
- 11.9 Pfizer
- 11.9.1 Pfizer Company Information
- 11.9.2 Pfizer Novel Drug Delivery Systems Product Offered
- 11.9.3 Pfizer Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.9.4 Pfizer Main Business Overview
- 11.9.5 Pfizer Latest Developments
- 11.10 Takeda
- 11.10.1 Takeda Company Information
- 11.10.2 Takeda Novel Drug Delivery Systems Product Offered
- 11.10.3 Takeda Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.10.4 Takeda Main Business Overview
- 11.10.5 Takeda Latest Developments
- 11.11 Bausch&Lomb
- 11.11.1 Bausch&Lomb Company Information
- 11.11.2 Bausch&Lomb Novel Drug Delivery Systems Product Offered
- 11.11.3 Bausch&Lomb Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.11.4 Bausch&Lomb Main Business Overview
- 11.11.5 Bausch&Lomb Latest Developments
- 11.12 Samyang Biopharmaceuticals
- 11.12.1 Samyang Biopharmaceuticals Company Information
- 11.12.2 Samyang Biopharmaceuticals Novel Drug Delivery Systems Product Offered
- 11.12.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.12.4 Samyang Biopharmaceuticals Main Business Overview
- 11.12.5 Samyang Biopharmaceuticals Latest Developments
- 11.13 Johnson & Johnson
- 11.13.1 Johnson & Johnson Company Information
- 11.13.2 Johnson & Johnson Novel Drug Delivery Systems Product Offered
- 11.13.3 Johnson & Johnson Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.13.4 Johnson & Johnson Main Business Overview
- 11.13.5 Johnson & Johnson Latest Developments
- 11.14 TOLMAR
- 11.14.1 TOLMAR Company Information
- 11.14.2 TOLMAR Novel Drug Delivery Systems Product Offered
- 11.14.3 TOLMAR Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.14.4 TOLMAR Main Business Overview
- 11.14.5 TOLMAR Latest Developments
- 11.15 Astellas
- 11.15.1 Astellas Company Information
- 11.15.2 Astellas Novel Drug Delivery Systems Product Offered
- 11.15.3 Astellas Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.15.4 Astellas Main Business Overview
- 11.15.5 Astellas Latest Developments
- 11.16 AMAG Pharmaceuticals
- 11.16.1 AMAG Pharmaceuticals Company Information
- 11.16.2 AMAG Pharmaceuticals Novel Drug Delivery Systems Product Offered
- 11.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.16.4 AMAG Pharmaceuticals Main Business Overview
- 11.16.5 AMAG Pharmaceuticals Latest Developments
- 11.17 AbbVie
- 11.17.1 AbbVie Company Information
- 11.17.2 AbbVie Novel Drug Delivery Systems Product Offered
- 11.17.3 AbbVie Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.17.4 AbbVie Main Business Overview
- 11.17.5 AbbVie Latest Developments
- 11.18 Dr Reddy
- 11.18.1 Dr Reddy Company Information
- 11.18.2 Dr Reddy Novel Drug Delivery Systems Product Offered
- 11.18.3 Dr Reddy Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.18.4 Dr Reddy Main Business Overview
- 11.18.5 Dr Reddy Latest Developments
- 11.19 AstraZeneca
- 11.19.1 AstraZeneca Company Information
- 11.19.2 AstraZeneca Novel Drug Delivery Systems Product Offered
- 11.19.3 AstraZeneca Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.19.4 AstraZeneca Main Business Overview
- 11.19.5 AstraZeneca Latest Developments
- 11.20 Aspen
- 11.20.1 Aspen Company Information
- 11.20.2 Aspen Novel Drug Delivery Systems Product Offered
- 11.20.3 Aspen Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.20.4 Aspen Main Business Overview
- 11.20.5 Aspen Latest Developments
- 11.21 Acrotech Biopharma
- 11.21.1 Acrotech Biopharma Company Information
- 11.21.2 Acrotech Biopharma Novel Drug Delivery Systems Product Offered
- 11.21.3 Acrotech Biopharma Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.21.4 Acrotech Biopharma Main Business Overview
- 11.21.5 Acrotech Biopharma Latest Developments
- 11.22 TWi Pharmaceuticals
- 11.22.1 TWi Pharmaceuticals Company Information
- 11.22.2 TWi Pharmaceuticals Novel Drug Delivery Systems Product Offered
- 11.22.3 TWi Pharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
- 11.22.4 TWi Pharmaceuticals Main Business Overview
- 11.22.5 TWi Pharmaceuticals Latest Developments
- 12 Research Findings and Conclusion
Table 1. Novel Drug Delivery Systems Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Liposomes
Table 3. Major Players of PEGylated Proteins & Polypeptides
Table 4. Major Players of Polymer Nanoparticle
Table 5. Major Players of Protein–drug Conjugates
Table 6. Major Players of Others
Table 7. Novel Drug Delivery Systems Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Novel Drug Delivery Systems Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Novel Drug Delivery Systems Market Size Market Share by Type (2019-2024)
Table 10. Novel Drug Delivery Systems Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Novel Drug Delivery Systems Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Novel Drug Delivery Systems Market Size Market Share by Application (2019-2024)
Table 13. Global Novel Drug Delivery Systems Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Novel Drug Delivery Systems Revenue Market Share by Player (2019-2024)
Table 15. Novel Drug Delivery Systems Key Players Head office and Products Offered
Table 16. Novel Drug Delivery Systems Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Novel Drug Delivery Systems Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Novel Drug Delivery Systems Market Size Market Share by Regions (2019-2024)
Table 21. Global Novel Drug Delivery Systems Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Novel Drug Delivery Systems Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Novel Drug Delivery Systems Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Novel Drug Delivery Systems Market Size Market Share by Country (2019-2024)
Table 25. Americas Novel Drug Delivery Systems Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Novel Drug Delivery Systems Market Size Market Share by Type (2019-2024)
Table 27. Americas Novel Drug Delivery Systems Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Novel Drug Delivery Systems Market Size Market Share by Application (2019-2024)
Table 29. APAC Novel Drug Delivery Systems Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Novel Drug Delivery Systems Market Size Market Share by Region (2019-2024)
Table 31. APAC Novel Drug Delivery Systems Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Novel Drug Delivery Systems Market Size Market Share by Type (2019-2024)
Table 33. APAC Novel Drug Delivery Systems Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Novel Drug Delivery Systems Market Size Market Share by Application (2019-2024)
Table 35. Europe Novel Drug Delivery Systems Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Novel Drug Delivery Systems Market Size Market Share by Country (2019-2024)
Table 37. Europe Novel Drug Delivery Systems Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Novel Drug Delivery Systems Market Size Market Share by Type (2019-2024)
Table 39. Europe Novel Drug Delivery Systems Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Novel Drug Delivery Systems Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Novel Drug Delivery Systems Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Novel Drug Delivery Systems Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Novel Drug Delivery Systems Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Novel Drug Delivery Systems Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Novel Drug Delivery Systems Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Novel Drug Delivery Systems Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Novel Drug Delivery Systems
Table 48. Key Market Challenges & Risks of Novel Drug Delivery Systems
Table 49. Key Industry Trends of Novel Drug Delivery Systems
Table 50. Global Novel Drug Delivery Systems Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Novel Drug Delivery Systems Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Novel Drug Delivery Systems Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Novel Drug Delivery Systems Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Amgen Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 55. Amgen Novel Drug Delivery Systems Product Offered
Table 56. Amgen Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Amgen Main Business
Table 58. Amgen Latest Developments
Table 59. Teva Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 60. Teva Novel Drug Delivery Systems Product Offered
Table 61. Teva Main Business
Table 62. Teva Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Teva Latest Developments
Table 64. Roche Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 65. Roche Novel Drug Delivery Systems Product Offered
Table 66. Roche Main Business
Table 67. Roche Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Roche Latest Developments
Table 69. UCB (Union Chimique Belge) Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 70. UCB (Union Chimique Belge) Novel Drug Delivery Systems Product Offered
Table 71. UCB (Union Chimique Belge) Main Business
Table 72. UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. UCB (Union Chimique Belge) Latest Developments
Table 74. Celgene Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 75. Celgene Novel Drug Delivery Systems Product Offered
Table 76. Celgene Main Business
Table 77. Celgene Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Celgene Latest Developments
Table 79. Merck Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 80. Merck Novel Drug Delivery Systems Product Offered
Table 81. Merck Main Business
Table 82. Merck Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Merck Latest Developments
Table 84. Gilead Sciences Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 85. Gilead Sciences Novel Drug Delivery Systems Product Offered
Table 86. Gilead Sciences Main Business
Table 87. Gilead Sciences Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Gilead Sciences Latest Developments
Table 89. Sanofi Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 90. Sanofi Novel Drug Delivery Systems Product Offered
Table 91. Sanofi Main Business
Table 92. Sanofi Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Sanofi Latest Developments
Table 94. Pfizer Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 95. Pfizer Novel Drug Delivery Systems Product Offered
Table 96. Pfizer Main Business
Table 97. Pfizer Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Pfizer Latest Developments
Table 99. Takeda Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 100. Takeda Novel Drug Delivery Systems Product Offered
Table 101. Takeda Main Business
Table 102. Takeda Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Takeda Latest Developments
Table 104. Bausch&Lomb Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 105. Bausch&Lomb Novel Drug Delivery Systems Product Offered
Table 106. Bausch&Lomb Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Bausch&Lomb Main Business
Table 108. Bausch&Lomb Latest Developments
Table 109. Samyang Biopharmaceuticals Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 110. Samyang Biopharmaceuticals Novel Drug Delivery Systems Product Offered
Table 111. Samyang Biopharmaceuticals Main Business
Table 112. Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Samyang Biopharmaceuticals Latest Developments
Table 114. Johnson & Johnson Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 115. Johnson & Johnson Novel Drug Delivery Systems Product Offered
Table 116. Johnson & Johnson Main Business
Table 117. Johnson & Johnson Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Johnson & Johnson Latest Developments
Table 119. TOLMAR Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 120. TOLMAR Novel Drug Delivery Systems Product Offered
Table 121. TOLMAR Main Business
Table 122. TOLMAR Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. TOLMAR Latest Developments
Table 124. Astellas Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 125. Astellas Novel Drug Delivery Systems Product Offered
Table 126. Astellas Main Business
Table 127. Astellas Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Astellas Latest Developments
Table 129. AMAG Pharmaceuticals Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 130. AMAG Pharmaceuticals Novel Drug Delivery Systems Product Offered
Table 131. AMAG Pharmaceuticals Main Business
Table 132. AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. AMAG Pharmaceuticals Latest Developments
Table 134. AbbVie Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 135. AbbVie Novel Drug Delivery Systems Product Offered
Table 136. AbbVie Main Business
Table 137. AbbVie Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 138. AbbVie Latest Developments
Table 139. Dr Reddy Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 140. Dr Reddy Novel Drug Delivery Systems Product Offered
Table 141. Dr Reddy Main Business
Table 142. Dr Reddy Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 143. Dr Reddy Latest Developments
Table 144. AstraZeneca Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 145. AstraZeneca Novel Drug Delivery Systems Product Offered
Table 146. AstraZeneca Main Business
Table 147. AstraZeneca Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 148. AstraZeneca Latest Developments
Table 149. Aspen Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 150. Aspen Novel Drug Delivery Systems Product Offered
Table 151. Aspen Main Business
Table 152. Aspen Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 153. Aspen Latest Developments
Table 154. Acrotech Biopharma Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 155. Acrotech Biopharma Novel Drug Delivery Systems Product Offered
Table 156. Acrotech Biopharma Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 157. Acrotech Biopharma Main Business
Table 158. Acrotech Biopharma Latest Developments
Table 159. TWi Pharmaceuticals Details, Company Type, Novel Drug Delivery Systems Area Served and Its Competitors
Table 160. TWi Pharmaceuticals Novel Drug Delivery Systems Product Offered
Table 161. TWi Pharmaceuticals Main Business
Table 162. TWi Pharmaceuticals Novel Drug Delivery Systems Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 163. TWi Pharmaceuticals Latest Developments
Related Reports
Allows one individual to access the purchased report Read More
Allows all employees of an organization to access the purchased report. Internal sharing only Read More
Allows all employees of an organization to access the purchased report. It also permits the use of up to 4 paragraphs or 1 page of the report externally in whitepapers, press releases, and marketing collateral Read More
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (03 October, 2024)
- Notify To Team (03 October, 2024)
- Report updation (04 October, 2024)
- Report Quality Check (04 October, 2024)
- Report Dispatch (05 October, 2024)
- Hard Copy
Recently Viewed Products
Global Novel Drug Delivery Systems Market Growth (Status and Outlook) 2024-2030
We are friendly and approachable, give us a call.